Coherus Oncology, Inc. (CHRS)
1.335
+0.04
(+3.49%)
USD |
NASDAQ |
Dec 10, 16:00
1.35
+0.02
(+1.12%)
After-Hours: 20:00
Coherus Oncology EPS Diluted (Quarterly): -0.3021 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediciNova, Inc. | -0.0622 |
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
| Anavex Life Sciences Corp. | -0.1144 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.52M |
| Revenue (Quarterly) | 11.57M |
| Total Expenses (Quarterly) | 56.09M |
| Enterprise Value | 18.58M |
| Gross Profit Margin (Quarterly) | 59.49% |
| Profit Margin (Quarterly) | -384.7% |
| Earnings Yield | -118.8% |
| Normalized Earnings Yield | -114.80 |